Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jonathan D. Bui is active.

Publication


Featured researches published by Jonathan D. Bui.


Stroke | 2001

Estrogens Decrease Reperfusion-Associated Cortical Ischemic Damage An MRI Analysis in a Transient Focal Ischemia Model

Jiong Shi; Jonathan D. Bui; Shao Hua Yang; Zhen He; Timothy H. Lucas; David L. Buckley; Stephen J. Blackband; Michael A. King; Arthur L. Day; James W. Simpkins

Background and Purpose— Early identification of irreversible cerebral ischemia is critical in defining strategies that influence neuronal survival after stroke. We used MRI to investigate the effects of 17&bgr;-estradiol (E2) on the temporal evolution of focal ischemia. Methods— Female rats were ovariectomized and divided into 1 of 2 groups: ovariectomy alone (OVX; n=4) or ovariectomy with estrogen replacement (OVX+E2; n=3). Both groups were then subjected to 1-hour middle cerebral artery occlusion (MCAO), with the use of a standardized endovascular monofilament model, followed by reperfusion. Sequential diffusion-weighted (DWI) and T2-weighted (T2WI) MRI were obtained during and after the MCAO. In separate groups of animals (n=5 for OVX and OVX+E2), cerebral blood flow (CBF) was measured by laser-Doppler methods before, during, and after occlusion. Results— DWI detected similar lesion characteristics during MCAO in both groups. In the OVX group, lesion size did not change during reperfusion, but the signal intensity ratio increased early and stabilized during the latter stages. In contrast, DWI lesion size decreased during reperfusion in OVX+E2 rats by 50% to 60% (P <0.05), a size reduction almost exclusively limited to cortical regions. During MCAO, the signal intensity ratio in OVX+E2 rats was reduced compared with OVX rats. Reperfusion further attenuated the signal intensity ratio in cortical but not subcortical regions (P <0.05 versus OVX). T2WI revealed no lesions in either group during MCAO, but it detected lesion sizes similar to that of DWI during reperfusion. Furthermore, similar patterns and magnitudes of estrogen treatment-related decrease in lesion size were noted after reperfusion. T2WI demonstrated less intense signal intensity ratio changes in both groups compared with DWI. There were no differences in CBF between groups either during occlusion, early reperfusion, or 1 day after reperfusion. Conclusions— This study strongly suggests that estrogens selectively protect cortical tissue from ischemic damage during MCAO and that this protection is exerted during both the occlusion and reperfusion phases of ischemia and does not involve an estrogen-related change in CBF.


European Journal of Pharmacology | 1992

Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier

Jonathan D. Bui; Birgitta Kimura; M. Ian Phillips

Recently several novel nonpeptide antagonists of angiotensin II (Ang II) have been identified. One of these, losartan potassium (formerly DuP 753) was developed as an orally active and highly selective antagonist for Ang II. As it is inhibited by sulfhydryl agents, it is specific for the AT1 receptor subtype. Since Ang II has both central and peripheral effects, we investigated whether losartan, given p.o. chronically, crosses the blood-brain barrier. The effects of chronic administration of losartan orally (p.o.) at 3 mg/kg per day for three days on the dipsogenic and pressor responses to a pre-established dose of Ang II i.v.t. (50 ng) were studied. Three series of experiments were carried out using conscious normotensive Sprague-Dawley rats. The rats were injected with Ang II intraventricularly (i.v.t.) before and after treatment of losartan p.o. and blood pressure and drinking responses measured. The experiments established that 3 mg/kg losartan p.o. for 3 days antagonized pressor effects of Ang II intravenously (i.v.), but did not antagonize the pressor or drinking effects of Ang II i.v.t. Daily water intake significantly increased with chronic losartan p.o.. Since chronic administration of losartan p.o. was able to block the effects of Ang II i.v. but had no effect on Ang II i.v.t. we conclude that losartan potassium does not readily cross the blood-brain barrier using this dose regimen.


Magnetic Resonance in Medicine | 2001

Two-component diffusion tensor MRI of isolated perfused hearts

Edward W. Hsu; David L. Buckley; Jonathan D. Bui; Stephen J. Blackband; John R. Forder

Nonmonoexponential MR diffusion decay behavior has been observed at high diffusion‐weighting strengths for cell aggregates and tissues, including the myocardium; however, implications for myocardial MR diffusion tensor imaging are largely unknown. In this study, a slow‐exchange‐limit, two‐component diffusion tensor model was fitted to diffusion‐weighted images obtained in isolated, perfused rat hearts. Results indicate that there are at least two distinct components of anisotropic diffusion, characterized by a “fast” component whose principal diffusivity is comparable to that of the perfusate, and a highly anisotropic “slow” component. It is speculated that the two components correspond to tissue compartments and have a general agreement with the orientations of anisotropy, or fiber orientations, in the myocardium. Moreover, consideration of previous studies of myocardial diffusion suggests that the presently observed fast component may likely be dominated by diffusion in the vascular space, whereas the slow component may include the intracellular and interstitial compartments. The implications of the results for myocardial fiber orientation mapping and limitations of the current two‐component model used are also discussed. Magn Reson Med 45:1039–1045, 2001.


Circulation | 2000

Antisense Inhibition of β1-Adrenergic Receptor mRNA in a Single Dose Produces a Profound and Prolonged Reduction in High Blood Pressure in Spontaneously Hypertensive Rats

Yuan Clare Zhang; Jonathan D. Bui; Leping Shen; M. Ian Phillips

Background —β-Blockers are the first line of therapy for hypertension. However, they are associated with side effects because of central nervous system (CNS) effects and β 2 -adrenergic antagonism. To overcome these problems and provide a long-term β 1 -blockade, antisense oligonucleotides against rat β 1 -adrenergic receptor (β 1 -AR) mRNA (β 1 -AS-ODN) were designed and tested for the ability to inhibit cardiac β 1 -ARs as well as lower blood pressure in spontaneously hypertensive rats (SHRs). Methods and Results —Radioligand binding assay showed that a single intravenous injection of β 1 -AS-ODN delivered in cationic liposomes significantly decreased cardiac β 1 -AR density by 30% to 50% for 18 days ( P 2 -ARs. This was accompanied by marked attenuation of β 1 -AR–mediated positive inotropic response in isolated perfused hearts in vitro ( P P 1 -AS-ODN effects on the CNS, which demonstrated no changes in β 1 -ARs in brain, in contrast to a significant reduction in heart and kidney ( P Conclusions —These results indicate that β 1 -AS-ODN, a novel approach to specific β 1 -blockade, has advantages over currently used β-blockers in providing a profound and prolonged reduction in blood pressure without affecting heart rate, β 2 -ARs, and the CNS. Diminished cardiac contractility resulting from less β 1 -AR expression contributes to the antihypertensive effect.


NeuroImage | 2009

Magnetic resonance microscopy of mammalian neurons.

Jeremy J. Flint; Choong-Heon Lee; Brian Benjamin Hansen; Michael Fey; Daniel Schmidig; Jonathan D. Bui; Michael A. King; Peter Vestergaard-Poulsen; Stephen J. Blackband

Magnetic resonance imaging (MRI) is now a leading diagnostic technique. As technology has improved, so has the spatial resolution achievable. In 1986 MR microscopy (MRM) was demonstrated with resolutions in the tens of micrometers, and is now an established subset of MRI with broad utility in biological and non-biological applications. To date, only large cells from plants or aquatic animals have been imaged with MRM limiting its applicability. Using newly developed microsurface coils and an improved slice preparation technique for correlative histology, we report here for the first time direct visualization of single neurons in the mammalian central nervous system (CNS) using native MR signal at a resolution of 4-8 microm. Thus MRM has matured into a viable complementary cellular imaging technique in mammalian tissues.


Journal of Neuroscience Methods | 1999

Probing intracellular dynamics in living cells with near-field optics

Jonathan D. Bui; Tibor Zelles; Hua Jane Lou; Valerie L Gallion; M. Ian Phillips; Weihong Tan

Near-field optics (NFO) overcomes the diffraction limit of light microscopes and permits visualization of single molecules. However, despite numerous applications of NFO in the physical sciences, there is still a paucity of applications in the neurosciences. In this work, the authors have developed NFO probes to image intracellular dynamic processes in living cells. This is the first time a NFO probe has been inserted inside a living cell to deliver light to a spatially controlled region for optical measurements and to record cellular responses to external stimuli. Two different optical detection systems (CCD camera and avalanche photon detection) were developed to monitor cellular responses to drug administration in two different cell types. NG108-15 neuroblastoma cells and vascular smooth muscle cells (VSMC) were penetrated with NFO probes. Intracellular Ca2+ increases post drug stimulation were detected by NFO probes. The cells were loaded with either fura-2/AM or fluo-3/AM calcium dyes. VSMC were stimulated with angiotensin II, resulting in a precise area of intracellular Ca2+ increase. Different response profiles of Ca2+ increases were observed after ionomycin and bradykinin administration in NG108-15 cells. Responsive heterogeneities due to ionomycin among different cells of the same type were recorded. The results show that NFO probes make possible real-time visualization of intracellular events. With refinement, intracellular NFO probes offer the potential of probing cell function with fast temporal and excellent spatial resolutions.


Neuroscience | 1999

Nuclear magnetic resonance imaging measurements of water diffusion in the perfused hippocampal slice during N-methyl-d-aspartate-induced excitotoxicity

Jonathan D. Bui; David L. Buckley; M.I. Phillips; S.J. Blackband

Significant changes in the apparent diffusion coefficient of water are observed in nuclear magnetic resonance images of patients with acute ischemic stroke. However, the underlying mechanisms of these apparent diffusion coefficient changes are still unresolved. To analyse possible mechanisms, this study applies nuclear magnetic resonance imaging on a 14.1 Tesla narrow-bore magnet to quantitatively study water diffusion in individually perfused brain slices following exposure to N-methyl-D-aspartate excitotoxicity. The results indicate that brain slices have at least two distinct diffusing water compartments with apparent diffusion coefficients of 0.96+/-0.10x10(-3) mm2/s and 0.06+/-0.01x10(-3) mm2/s. When excitotoxicity was induced with N-methyl-D-aspartate, there was a significant decrease in the fraction of the fast diffusing water component in the slices (P<0.001). However, neither apparent diffusion coefficient changed significantly. Prior treatment with dizocilpine maleate (MK-801) depressed the effects of N-methyl-D-aspartate (P<0.01, ANOVA). The results demonstrate brain slice compartmental changes resulting from direct receptor stimulation and provide evidence for tissue water redistribution as an important mechanism for changes in apparent diffusion coefficient seen in clinical magnetic resonance imaging. The brain slice preparation affords a well-controlled method to study the mechanisms of tissue nuclear magnetic resonance contrast, bridging the gap between basic nuclear magnetic resonance studies and clinical magnetic resonance imaging. The brain slice model also offers a new way to test the utility of potential anti-stroke drugs using high field nuclear magnetic resonance imaging.


Magnetic Resonance Materials in Physics Biology and Medicine | 1999

NMR microscopy—beginnings and new directions

Stephen J. Blackband; David L. Buckley; Jonathan D. Bui; M. Ian Phillips

In this paper we briefly review the origins of NMR microscopy, and in the spirit of the Sir Peter Mansfield Symposium of which this presentation was a part, point out especially Sir Mansfield and his co-workers contributions in this area. We then review some recent studies applying magnetic resonance (MR) microscopy focusing on our own contributions in these regards, in particular with reference to imaging of single neurons and more recent microimaging studies on isolated perfused brain slices. Finally we briefly describe recent preliminary studies on the feasibility of spectroscopic experiments that may be performed at the single cell level, further illustrating the growing scope and potential of magnetic resonance imaging (MRI) in general as a tool for examining biological systems non-invasively


Magnetic Resonance in Medicine | 1999

MRI measurement of cell volume fraction in the perfused rat hippocampal slice

David L. Buckley; Jonathan D. Bui; M. Ian Phillips; Stephen J. Blackband

T1‐weighted NMR imaging of the isolated perfused rat hippo‐campal slice was used to estimate cell volume fraction. Eight brain slices were studied in artificial cerebrospinal fluid (aCSF) using a 600 MHz narrow bore spectrometer and a home built perfusion chamber. Cell volume fraction was calculated as 1 − fECS, where fECS is the distribution volume of gadodiamide in the slice. This was determined by measuring the T1 of the slice before and after perfusion with gadodiamde. A mean cell volume fraction of 0.66 ± 0.04 was estimated. The addition of 60 mM mannitol to three of the brain slices produced a 26% decrease in the cell volume fraction. The technique affords a simple means of estimating cell volume fraction and can be extended to produce images reflecting cell density. Magn Reson Med 42:603–607, 1999.


Neuroscience | 1999

In vivo dynamics and distribution of intracerebroventricularly administered gadodiamide, visualized by magnetic resonance imaging

Jonathan D. Bui; D.R. Nammari; David L. Buckley; Benjamin A. Inglis; X. Silver; Thomas H. Mareci; M.I. Phillips

Direct injections into the cerebroventricles have been extensively utilized in neurophysiological studies. Mapping the distribution of injectate after intracerebroventricular injection has been made only by post mortem analysis, and the dynamic distribution of injectate within the brain has not been well characterized. In this report, we apply contrast-enhanced magnetic resonance imaging to study the pharmacokinetics and extent of non-ionic gadodiamide transport into brain tissue in vivo after intracerebroventricular administration. The results indicate that intracerebroventricular injectate travels quickly throughout the ventricular system from the lateral ventricular site of injection to the fourth ventricle and foramina of Luschka and Magendie within 2 min. After this, the signal intensity begins to increase in the periventricular and paraventricular brain parenchyma. Contrast enhancement is visible 2 mm into the brain tissue from the ventricles. Quantitative analysis of the data shows that the transport of gadodiamide across the ependymal layer that lines the cerebrospinal fluid space characterized a rate constant of 0.066+/-0.017 min(-1). These results provide a better understanding of chemical transport and diffusion following direct injection into the cerebroventricles. They provide information on the in vivo dynamics of injectate after intracerebroventricular administration, and show that contrast enhanced magnetic resonance imaging may be used to more precisely define the target sites of chemicals after intracerebroventricular administration into the brain.

Collaboration


Dive into the Jonathan D. Bui's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Ian Phillips

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge